Does LEUPROLIDE Cause Neoplasm malignant? 265 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 265 reports of Neoplasm malignant have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.4% of all adverse event reports for LEUPROLIDE.
265
Reports of Neoplasm malignant with LEUPROLIDE
0.4%
of all LEUPROLIDE reports
99
Deaths
57
Hospitalizations
How Dangerous Is Neoplasm malignant From LEUPROLIDE?
Of the 265 reports, 99 (37.4%) resulted in death, 57 (21.5%) required hospitalization, and 3 (1.1%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 265 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which LEUPROLIDE Alternatives Have Lower Neoplasm malignant Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM